share_log

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $48

Benzinga ·  Nov 13, 2023 18:07

HC Wainwright & Co. analyst Robert Burns maintains Replimune Group (NASDAQ:REPL) with a Buy and lowers the price target from $50 to $48.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment